Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3194057
Max Phase: Preclinical
Molecular Formula: C14H16N6O3
Molecular Weight: 316.32
Molecule Type: Small molecule
Associated Items:
ID: ALA3194057
Max Phase: Preclinical
Molecular Formula: C14H16N6O3
Molecular Weight: 316.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(/C=N/NC(=O)CNc1nnc(O)nc1O)c1ccccc1
Standard InChI: InChI=1S/C14H16N6O3/c1-9(10-5-3-2-4-6-10)7-16-18-11(21)8-15-12-13(22)17-14(23)20-19-12/h2-7,9H,8H2,1H3,(H,15,19)(H,18,21)(H2,17,20,22,23)/b16-7+
Standard InChI Key: OBJBBUMAIIQXIZ-FRKPEAEDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 316.32 | Molecular Weight (Monoisotopic): 316.1284 | AlogP: 0.60 | #Rotatable Bonds: 6 |
Polar Surface Area: 132.62 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.12 | CX Basic pKa: 2.52 | CX LogP: 0.92 | CX LogD: 0.92 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.45 | Np Likeness Score: -1.25 |
1. PubChem BioAssay data set, |
Source(1):